Cue Biopharma Announces Changes to its Board of Directors

NEXT STORY
AB Science provides update on masitinib programs timelines
PREV STORY
Sorrento Therapeutics Announces Closing of $25 Million Registered Direct Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nasdaq Welcomes TiGenix NV (Nasdaq: TIG) to The Nasdaq Stock Market

NEW YORK, Dec. 15, 2016 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market today announces ...

author_avatar
NASDAQ Market News

Northeast Business Group on Health Releases Employer Guide to Genomic Medicine

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Northeast Business Group on Health (NEBGH) ...

author_avatar
NASDAQ Market News

Galena Biopharma Announces Pricing of Registered Direct Offering

SAN RAMON, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News